EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 48 filers reported holding EPIZYME INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $6,096,000 | -5.0% | 355,445 | -33.0% | 0.19% | -3.1% |
Q4 2016 | $6,416,000 | -23.3% | 530,281 | -37.6% | 0.20% | -38.1% |
Q3 2016 | $8,368,000 | -15.9% | 850,446 | -12.5% | 0.32% | -54.0% |
Q2 2016 | $9,953,000 | -30.5% | 971,946 | -17.7% | 0.68% | -22.0% |
Q1 2016 | $14,317,000 | +50.1% | 1,181,244 | +98.4% | 0.88% | +64.1% |
Q4 2015 | $9,537,000 | +13.4% | 595,314 | -8.9% | 0.54% | +85.8% |
Q3 2015 | $8,408,000 | -42.6% | 653,828 | +7.1% | 0.29% | +29.7% |
Q2 2015 | $14,651,000 | -6.1% | 610,442 | -26.5% | 0.22% | -74.5% |
Q1 2015 | $15,606,000 | -12.3% | 831,000 | -11.9% | 0.87% | -2.4% |
Q4 2014 | $17,798,000 | -35.0% | 943,200 | -6.6% | 0.89% | -36.8% |
Q3 2014 | $27,370,000 | -12.9% | 1,009,600 | 0.0% | 1.41% | -17.1% |
Q2 2014 | $31,419,000 | +188.9% | 1,009,600 | +111.3% | 1.70% | +173.2% |
Q1 2014 | $10,877,000 | +318.3% | 477,700 | +282.2% | 0.62% | +309.2% |
Q4 2013 | $2,600,000 | -48.0% | 125,000 | 0.0% | 0.15% | -55.3% |
Q3 2013 | $5,000,000 | +42.2% | 125,000 | 0.0% | 0.34% | +44.1% |
Q2 2013 | $3,516,000 | – | 125,000 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |